This topic contains a solution. Click here to go to the answer

Author Question: Information may be released without prior consent to a health professional who is directly involved ... (Read 47 times)

kellyjaisingh

  • Hero Member
  • *****
  • Posts: 540
Information may be released without prior consent to a health professional who is directly involved in the care and treatment of the inmate in an emergency situation or when the inmate is unable to sign.
 
 Indicate whether the statement is true or false

Question 2

What is a significant barrier to providing inmates with adequate health care?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

paavo

  • Sr. Member
  • ****
  • Posts: 301
Answer to Question 1

TRUE

Answer to Question 2

One of the biggest barriers comes from a lack of access to inmate health information from hospitals and clinics. Uninformed or misinformed staff often refuse to release inmate health records to correctional facilities for the continued treatment of inmates.




kellyjaisingh

  • Member
  • Posts: 540
Reply 2 on: Jul 12, 2018
:D TYSM


matt95

  • Member
  • Posts: 317
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

The average adult has about 21 square feet of skin.

Did you know?

In 2012, nearly 24 milliion Americans, aged 12 and older, had abused an illicit drug, according to the National Institute on Drug Abuse (NIDA).

Did you know?

Many people have small pouches in their colons that bulge outward through weak spots. Each pouch is called a diverticulum. About 10% of Americans older than age 40 years have diverticulosis, which, when the pouches become infected or inflamed, is called diverticulitis. The main cause of diverticular disease is a low-fiber diet.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library